Development and validation of a bioanalytical LC-UV method with solid-phase extraction for determination of valproic acid in saliva
By: Jasmina Tonic-Ribarska, Arlinda Haxhiu, Zoran Sterjev, Gordana Kiteva, Ljubica Suturkova and Suzana Trajkovic-Jolevska
Open Access
|Jun 2012References
- P. Loiseau, Rational use of valproate: Indications and drug regimen in epilepsy,(1984) 65-72; DOI: 10.1111/j.1528-1157.1984.tb05641.x.
- O. Dulac, D. Steru, E. Rey and M. Arthius, Sodium valproate monotherapy in childhood epilepsy,.(1986) 47-52.
- D. C. Lagacea, W. T. O'Brienb, N. Gurvichb, M. W. Nachtigala and P. S. Klein, Valproic acid: How it works. Or not,.(2004) 215-225; DOI: 10.1016/j.cnr.2004.09.013.
- P. Wal, B. Kumar, A. Bhandari, A. K. Rai and A. Wal, Bioanalytical method development - Determination of drugs in biological fluids,.(2010) 333-347.
- S. I. Johannessen,, in(Ed. G. Hempel) in Elsevier, Amsterdan 2004, in (Ed. R. M. Smith). Vol. 5, pp. 221-253; DOI: 10.1016/S1567-7192(04)80010-X.
- P. N. Patsalos, D. J. Berry, B. F. D. Bourgeois, J. C. Cloyd, T. A. Glauser, S. I. Johannessen, I. E. Leppik, T. Tomson and E. P. Patsalos, Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on the therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies,(2008) 1-38; DOI: 10.1111/j.1528-1167.2008.01561.x.
- S. J. Soldin, Free drug measurement,.(1999) 822-823.
- H. Liu and M. R. Delgado, Therapeutic drug concentration monitoring using saliva samples,.(1999) 453-470; DOI: 10.2165/00003088-199936060-00006.
- H. S. Chung, T. L. Seung and L. Soo-Youn, Evaluation of Viva-E drug testing system,.(2007) 330-337; DOI: 10.3343/kjlm.2007.27.5.330.
- R. L. Dills and D. D. Shen, Methods to reduce background interferences in electron-capture gas chromathographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide,(1997) 139-152; DOI: 10.1016/S0378-4347(96)00405-7.
- S. Rompotis, M. Parissi-Poulou, E. Gikas, M. Kazanis, A. Vavayannis and I. Panderi, Determination of valproic acid in human plasma by HPLC with fluorescence detection,(2002) 2833-2847; DOI: 10.1081/JLC-120014953.
- H. Amini, M. Javan and A. Ahmadiani, Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization,(2006) 368-371; DOI: 10.1016/j.jchromb.2005.11.028.
- D. S. Jain, G. Subbaiah, M. Sanyal and P. Shrivastav, A high through and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS,(2007) 80-88.
- , European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), London 2009;
- M. Krogh, K. Johansen, F. Tonnesen and K. E. Rasmussen, Solid-phase microextraction for the determination of the free concentration of valproic acid in human plasma by capillary gas chromatography,(1995) 299-305; DOI: 10.1016/03784347(95)00273-8.
Language: English, Croatian, Slovenian
Page range: 211 - 220
Published on: Jun 28, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2012 Jasmina Tonic-Ribarska, Arlinda Haxhiu, Zoran Sterjev, Gordana Kiteva, Ljubica Suturkova, Suzana Trajkovic-Jolevska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.